000 | 01179 a2200337 4500 | ||
---|---|---|---|
005 | 20250518080100.0 | ||
264 | 0 | _c20200618 | |
008 | 202006s 0 0 eng d | ||
022 | _a1523-1755 | ||
024 | 7 |
_a10.1016/j.kint.2019.08.039 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeón-Jiménez, David | |
245 | 0 | 0 |
_aIs the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease? _h[electronic resource] |
260 |
_bKidney international _c01 2020 |
||
300 |
_a213 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aBenzhydryl Compounds |
650 | 0 | 4 | _aDiabetes Mellitus, Type 2 |
650 | 0 | 4 | _aDiabetic Nephropathies |
650 | 0 | 4 | _aDiuretics |
650 | 0 | 4 | _aGlucosides |
650 | 0 | 4 | _aHemodynamics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRenal Insufficiency, Chronic |
650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
700 | 1 | _aMoreno-Obregón, Fernando | |
700 | 1 | _aBeltrán-Romero, Luis M | |
700 | 1 | _aMiramontes-González, José Pablo | |
773 | 0 |
_tKidney international _gvol. 97 _gno. 1 _gp. 213 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.kint.2019.08.039 _zAvailable from publisher's website |
999 |
_c30483294 _d30483294 |